Aurobindo Pharma declines 6% on USFDA warning letter for Dayton facility
newsdepo.com
The company said it would engage with the regulator and would try to resolve the issue at the earliestAurobindo Pharma declines 6% on USFDA warning letter for Dayton facility
The company said it would engage with the regulator and would try to resolve the issue at the earliest Read more